| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,310,000,000 |
| Market
Cap: |
73.32(B) |
| Last
Volume: |
16,616,000 |
Avg
Vol: |
7,672,242 |
| 52
Week Range: |
$55.15 - $81.42 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : 10.7 |
| Insider 6 Months : 10.7 |
| Insider 3/6 Months : 21.5 |
|
| Guru Rank Number : 214 |
| Guru Rank Value : 5.7 |
| Guru Occurances : 5 |
|
|
|
|
|
| |
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
10,181 |
10,181 |
12,181 |
26,181 |
| Total Buy Value |
$554,173 |
$554,173 |
$695,103 |
$1,671,670 |
| Total People Bought |
2 |
2 |
2 |
3 |
| Total Buy Transactions |
2 |
2 |
3 |
4 |
| Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
| Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
| Total People Sold |
1 |
1 |
2 |
5 |
| Total Sell Transactions |
1 |
1 |
2 |
7 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Balser Jeffrey R. |
Director |
– • – |
2022-09-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
218 |
|
-17% |
|
| Balser Jeffrey R. |
Director |
• • – |
2022-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
406 |
624 |
|
- |
|
| Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
• • – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,735 |
12,735 |
|
- |
|
| Shah Prem S |
EVP and Co-President of Retail |
• • – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,376 |
20,376 |
|
- |
|
| Mandadi Tilak |
EVP, Chief Technology Officer |
• • – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
99,847 |
99,847 |
|
- |
|
| Lotvin Alan |
EVP&President-PharmacyServices |
• • – |
2022-08-04 |
4 |
AS |
$104.00 |
$2,344,264 |
D/D |
(22,541) |
109,183 |
|
-4% |
|
| Lotvin Alan |
EVP&President-PharmacyServices |
• • – |
2022-08-04 |
4 |
OE |
$62.21 |
$1,402,276 |
D/D |
22,541 |
131,724 |
|
- |
|
| Finke Daniel P |
EVP/Pres, Health Care Benefits |
• • – |
2022-08-03 |
4 |
AS |
$100.00 |
$954,600 |
D/D |
(9,546) |
32,150 |
|
-1% |
|
| Finke Daniel P |
EVP/Pres, Health Care Benefits |
• • – |
2022-08-03 |
4 |
OE |
$52.37 |
$499,924 |
D/D |
9,546 |
41,696 |
|
- |
|
| Lotvin Alan |
EVP&President-PharmacyServices |
• • – |
2022-08-03 |
4 |
AS |
$98.00 |
$11,848,102 |
D/D |
(120,899) |
109,183 |
|
-1% |
|
| Lotvin Alan |
EVP&President-PharmacyServices |
• • – |
2022-08-03 |
4 |
OE |
$54.19 |
$6,843,669 |
D/D |
120,899 |
159,684 |
|
- |
|
| Moriarty Thomas M |
EVP & General Counsel |
• • – |
2022-06-28 |
4 |
AS |
$95.00 |
$13,172,130 |
D/D |
(138,654) |
626,273 |
|
9% |
|
| Moriarty Thomas M |
EVP & General Counsel |
• • – |
2022-06-28 |
4 |
OE |
$54.19 |
$8,500,397 |
D/D |
138,654 |
665,146 |
|
- |
|
| Shah Prem S |
EVP and Co-President of Retail |
• – – |
2022-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
0 |
|
- |
|
| Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
• – – |
2022-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
0 |
|
- |
|
| Shah Prem S |
EVP and Co-President of Retail |
• • – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,671 |
20,671 |
|
- |
|
| Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
• • – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,919 |
12,919 |
|
- |
|
| Chaguturu Sreekanth K |
EVP and Chief Medical OfficerO |
• – – |
2022-05-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
15,805 |
|
- |
|
| Chaguturu Sreekanth K |
EVP and Chief Medical OfficerO |
• – – |
2022-05-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,805 |
|
2% |
|
| Aguirre Fernando |
Director |
• • – |
2022-05-11 |
4 |
A |
$97.99 |
$125,623 |
D/D |
1,282 |
27,526 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2022-05-11 |
4 |
A |
$97.99 |
$135,618 |
D/D |
1,384 |
5,892 |
|
- |
|
| Deparle Nancy Ann |
Director |
• • – |
2022-05-11 |
4 |
A |
$97.99 |
$133,070 |
D/D |
1,358 |
24,760 |
|
- |
|
| Ludwig Edward J |
Director |
• • – |
2022-05-11 |
4 |
A |
$97.99 |
$16,168 |
D/D |
165 |
18,499 |
|
- |
|
| White Tony L |
Director |
• • – |
2022-05-11 |
4 |
A |
$97.99 |
$3,724 |
D/D |
38 |
37,852 |
|
- |
|
| Dorman David W |
Director |
– • – |
2022-05-11 |
4 |
A |
$97.99 |
$4,997 |
D/D |
51 |
109,875 |
|
- |
|
1578 Records found
|
|
Page 4 of 64 |
|
|
0.07 (0.13%) 
